slides · global inventory
Image
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 119,566
Current window 86,401-86,430
Pages 3,986
Rows per page 30
Component
86,401-86,430 of 119,566
02
Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slidesAeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank Beat · Situation & Context1 hit
03
The slide details a corporate acquisition and concurrent private placement financing.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank Beat · Situation & Context1 hit
05
The slide uses a Gantt-style visualization to show the development status of various drug candidates.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank Beat · Problem & Complication1 hit
08
The slide uses a numbered list format to present the company's core strategic pillars.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank Beat · Problem & Complication1 hit
09
The chart illustrates the correlation between Cyno and Human half-life, showing YTE mAbs (Spyre's approach) outperforming WT mAbs.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank Beat · Solution & ApproachLoop · Golden Circle1 hit
17
The slide uses a Y-shaped antibody diagram to annotate specific functional improvements.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 1 hit
18
The slide uses a structural model of the protein complex and two dose-response curves to demonstrate efficacy and selectivity.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 1 hit
25
Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slidesAeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 1 hit
30
The slide uses an antibody diagram to annotate specific technical advantages of the SPY002 molecule.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 1 hit
34
The slide uses a 2x2 grid to summarize program strengths and a timeline for catalysts.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 1 hit
37
The slide uses a biological process diagram to illustrate drug targets (a4b7, TL1A, IL-23) and their corresponding therapeutic antibodies.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 1 hit
41
The slide uses a bispecific antibody illustration to represent the combination therapy approach.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 1 hit
44
Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slidesAeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 1 hit
03
The slide features logos and imagery for brands like Culture Kings, Petal & Pup, MNML, and Princess Polly.a.k.a. Brands | Investor Presentation Deck | 13 slides · a.k.a. Brands
Pitch deck Investor relations Beat · ProblemLoop · Why Now1 hit
04
The slide uses a contrast-pairs framework to differentiate the company from traditional retail incumbents.a.k.a. Brands | Investor Presentation Deck | 13 slides · a.k.a. Brands
Pitch deck Investor relations Beat · ProblemLoop · Why Now1 hit
05
The slide uses a table-like structure to map strategic pillars to operational outcomes.a.k.a. Brands | Investor Presentation Deck | 13 slides · a.k.a. Brands
Pitch deck Investor relations Beat · SolutionLoop · Why Now1 hit
07
Includes a source note for the 'Top 10 fashion website' claim.a.k.a. Brands | Investor Presentation Deck | 13 slides · a.k.a. Brands
Pitch deck Investor relations Beat · Market Size1 hit
09
The slide uses a mix of brand identity, business metrics, and lifestyle imagery to define the company's market position.a.k.a. Brands | Investor Presentation Deck | 13 slides · a.k.a. Brands
Pitch deck Investor relations Beat · Market Size1 hit
11
The slide uses a split-layout with a lifestyle image on the left and strategic bullet points on the right.a.k.a. Brands | Investor Presentation Deck | 13 slides · a.k.a. Brands
Pitch deck Investor relations Beat · TeamLoop · Quick Win Big Bet1 hit
12
The slide serves as a portfolio or proof-of-concept gallery demonstrating the company's capability in executing brand activations.a.k.a. Brands | Investor Presentation Deck | 13 slides · a.k.a. Brands
Pitch deck Investor relations Beat · TeamLoop · Quick Win Big Bet1 hit
13
a.k.a. Brands | Investor Presentation Deck | 13 slidesa.k.a. Brands | Investor Presentation Deck | 13 slides · a.k.a. Brands
Pitch deck Investor relations Beat · TeamLoop · Quick Win Big Bet1 hit
01
Alkermes | Investor Presentation Deck | 56 slidesAlkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
28
The slide uses a grid layout with headshots, biographical bullet points, and committee membership indicators.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
29
The slide uses a table-like structure to compare four board members.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
30
The slide uses a structured table format to map committees to their specific oversight domains.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
39
The slide uses a checkmark matrix to demonstrate board competency across five key areas: Neuroscience, Financial/Transactional, Commercial, Medical/R&D, and Global Business.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
46
Includes a diagram of brain pathways related to wakefulness and neurotransmitters.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
47
Includes a structural biology visualization of the Orexin 2 receptor.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
49
Includes a CEO quote and specific program metrics.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
56
Alkermes | Investor Presentation Deck | 56 slidesAlkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit